Clinical Update on Uses for Mifepristone in Obstetrics and Gynecology

被引:9
|
作者
Hagey, Jill M. [1 ]
Givens, Matthew [2 ]
Bryant, Amy G. [1 ]
机构
[1] Univ N Carolina, Dept Obstet & Gynecol, Div Complex Family Planning, Chapel Hill, NC 27515 USA
[2] Univ Utah, Dept Obstet & Gynecol, Div Maternal Fetal Med, Salt Lake City, UT USA
关键词
LOW-DOSE MIFEPRISTONE; RANDOMIZED CONTROLLED-TRIAL; MEDICAL ABORTION; DOUBLE-BLIND; EMERGENCY CONTRACEPTION; SUBLINGUAL MISOPROSTOL; EARLY-PREGNANCY; BREAST-CANCER; PHASE-II; VAGINAL MISOPROSTOL;
D O I
10.1097/OGX.0000000000001063
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Importance Mifepristone (RU-486) is a selective progesterone receptor modulator that has antagonist properties on the uterus and cervix. Mifepristone is an effective abortifacient, prompting limitations on its use in many countries. Mifepristone has many uses outside of induced abortion, but these are less well known and underutilized by clinicians because of challenges in accessing and prescribing this medication. Objective To provide clinicians with a history of the development of mifepristone and mechanism of action and safety profile, as well as detail current research on uses of mifepristone in both obstetrics and gynecology. Evidence Acquisition A PubMed search of mifepristone and gynecologic and obstetric conditions was conducted between January 2018 and December 2021. Other resources were also searched, including guidelines from the American College of Obstetricians and Gynecologists and the Society of Family Planning. Results Mifepristone is approved by the Food and Drug Administration for first-trimester medication abortion but has other off-label uses in both obstetrics and gynecology. Obstetric uses that have been investigated include management of early pregnancy loss, intrauterine fetal demise, treatment of ectopic pregnancy, and labor induction. Gynecologic uses that have been investigated include contraception, treatment of abnormal uterine bleeding, and as an adjunct in treatment of gynecologic cancers. Conclusions and Relevance Mifepristone is a safe and effective medication both for its approved use in first-trimester medication abortion and other off-label uses. Because of its primary use as an abortifacient, mifepristone is underutilized by clinicians. Providers should consider mifepristone for other indications as clinically appropriate. Target Audience Obstetricians and gynecologists, family physicians. Learning Objectives After completing this activity, the learner should be better able to describe the history of the development of mifepristone, including its mechanism of action and safety profile; and explain the uses for mifepristone in both obstetrics and gynecology.
引用
收藏
页码:611 / 623
页数:13
相关论文
共 50 条
  • [1] AN UPDATE IN OBSTETRICS GYNECOLOGY
    LEFEBVRE, Y
    [J]. UNION MEDICALE DU CANADA, 1983, 112 (02): : 96 - 96
  • [2] HYPNOSIS IN OBSTETRICS AND GYNECOLOGY, AN UPDATE
    TILTON, EB
    [J]. SOUTHERN MEDICAL JOURNAL, 1986, 79 (02) : 65 - 65
  • [3] Pharmaceutic Update Gynecology and Obstetrics
    Emons, G.
    Jonat, W.
    [J]. GYNAKOLOGE, 2014, 47 (07): : 465 - 465
  • [4] Off-label indications for mifepristone in gynecology and obstetrics
    Dzuba, Ilana G.
    Grossman, Daniel
    Schreiber, Courtney A.
    [J]. CONTRACEPTION, 2015, 92 (03) : 203 - 205
  • [6] Clinical uses of mifepristone: An update for women's health practitioners
    Beal, MW
    Simmonds, K
    [J]. JOURNAL OF MIDWIFERY & WOMENS HEALTH, 2002, 47 (06) : 451 - 460
  • [7] CLINICAL OBSTETRICS AND GYNECOLOGY
    SCHULMAN, H
    [J]. OBSTETRICS AND GYNECOLOGY, 1966, 27 (02): : 303 - &
  • [8] CLINICAL OBSTETRICS AND GYNECOLOGY
    不详
    [J]. OBSTETRICS AND GYNECOLOGY, 1966, 27 (05): : 749 - &
  • [9] Pharmaceutic update infections in obstetrics and gynecology
    Bauerschmitz, G. J.
    Emons, G.
    [J]. GYNAKOLOGE, 2014, 47 (07): : 477 - 481
  • [10] Update in Gynecology and Obstetrics: reviews and databases
    Délio Marques Conde
    Waldemar Naves Amaral
    Aarão Mendes Pinto-Neto
    Jurandyr Moreira de Andrade
    [J]. Archives of Gynecology and Obstetrics, 2008, 278 : 261 - 263